Laraway Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $511K | Hold |
7,406
| – | – | 0.39% | 65 |
|
|
2025
Q1 | $514K | Hold |
7,406
| – | – | 0.41% | 62 |
|
|
2024
Q4 | $637K | Hold |
7,406
| – | – | 0.49% | 54 |
|
|
2024
Q3 | $882K | Hold |
7,406
| – | – | 0.7% | 41 |
|
|
2024
Q2 | $1.06M | Hold |
7,406
| – | – | 0.9% | 33 |
|
|
2024
Q1 | $951K | Buy |
7,406
+50
| +0.7% | +$6.42K | 0.84% | 34 |
|
|
2023
Q4 | $761K | Sell |
7,356
-300
| -4% | -$31K | 0.72% | 37 |
|
|
2023
Q3 | $696K | Sell |
7,656
-400
| -5% | -$36.4K | 0.73% | 43 |
|
|
2023
Q2 | $652K | Sell |
8,056
-600
| -7% | -$48.5K | 0.64% | 48 |
|
|
2023
Q1 | $689K | Buy |
+8,656
| New | +$689K | 0.7% | 45 |
|